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Little information is available on the prevalence, geographic distribution and mutation spectrum of genetic skeletal
disorders (GSDs) in China. This study systematically reviewed GSDs as defined in “Nosology and Classification of
genetic skeletal disorders (2010 version)” using Chinese biomedical literature published over the past 34 years from
1978 to 2012. In total, 16,099 GSDs have been reported. The most frequently reported disorders were Marfan
syndrome, osteogenesis imperfecta, fibrous dysplasia, mucopolysaccharidosis, multiple cartilaginous exostoses,
neurofibromatosis type 1 (NF1), osteopetrosis, achondroplasia, enchondromatosis (Ollier), and osteopoikilosis, accounting
for 76.5% (12,312 cases) of the total cases. Five groups (group 8, 12, 14, 18, 21) defined by “Nosology and
Classification of genetic skeletal disorders” have not been reported in the Chinese biomedical literature. Gene
mutation testing was performed in only a minor portion of the 16,099 cases of GSDs (187 cases, 1.16%). In total,
37 genes for 41 different GSDs were reported in Chinese biomedical literature, including 43 novel mutations. This
review revealed a significant imbalance in rare disease identification in terms of geographic regions and hospital
levels, suggesting the need to create a national multi-level network to meet the specific challenge of care for rare
diseases in China.
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Genetic skeletal disorders (GSDs) arise from distur-
bances of the complex processes of skeletal develop-
ment, growth, and homeostasis caused by gene
mutations. These disorders represent a challenge in
terms of diagnosis and treatment due to their rarity and
variety [1,2]. The recently published “Nosology and Clas-
sification of Genetic skeletal disorders (2010 version)”
listed 456 GSDs that were classified into 40 groups by
clinical, radiographic, and molecular criteria; of these,
316 conditions were associated with mutations in 226
different genes [3]. The Nosology not only provides a
guideline for the diagnosis of the patients and the recog-
nition of the novel disorders for clinicians, but also is
helpful for better understanding the mechanisms of* Correspondence: samshjx@sina.com
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reproduction in any medium, provided the orgenes, proteins and pathways involved in skeletal
biology.
Until now, population-based studies to determine the
prevalence of GSDs have been not been performed in
China. Most GSDs have been reported in “case reports”
in Chinese biomedical literature, but these sources are
usually not available to international readers. Therefore,
an introduction to the published literature on GSDs in
China would enrich our knowledge on the prevalence
and molecular characteristics of these rare diseases.
This study systematically reviewed GSDs reported in
Chinese biomedical literature published over the past
34 years from January 1978 to January 2012. This study
also analyzed the current state and specific challenges in
diagnosing and treating rare diseases in China.Methods
Rare diseases covered
This bibliographic study covered a total of 456 GSDs in
40 groups defined in “Nosology and Classification of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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with the approval of the ethics committee of Shandong
Academy of Medical Science.
Selection of database sources
A literature search was conducted using China Biomed-
ical Database (CBM) (http://sinomed.imicams.ac.cn) and
covered sources from January 1978 to January 2012. The
CBM is the largest Chinese biomedical bibliographic
database [4], and includes a total of 6,840,907 articles
from more than 1,600 biomedical journals published in
Chinese prior to January 12, 2012.
Search strategy
The CBM database and public web search engines were
first used to search for alternative Chinese terms for the
English terms describing each disorder, and then all the
terms for the disorder (both in English and Chinese)
were used to search for publications in the CBM data-
base. English terms for disorders were included since
most Chinese biomedical articles contain an English ab-
stract. The following search algorithm was used: “English
disorder terms OR Chinese disorder terms [fulltext]”.
For diseases with different subtypes (for example, Osteo-
genesis Imperfecta, types I–V), only the main term
(“Osteogenesis Imperfecta”) was used in the search, and
information on the type was gleaned from the text.
Inclusion and exclusion criteria
Clinical data and diagnostic information were gleaned
from the abstract or full text of the articles searched for
in the CBM database. Cases of GSDs with a confirmed
diagnosis were included. Detailed clinical, imaging, and
laboratory data needed to be described for case reports.
Exact diagnostic criteria had to be included for research
reports involving multiple cases or families. For each
study included, informed consent to publication was
obtained from the patient. Patient medical information
was carefully compared for series of reports on the same
disorders by the same authors or institutions, and re-
dundant cases were excluded.
Results
According to our criteria 3,208 Chinese reports were
qualified for inclusion. A total of 16,099 cases of GSDs
in 35 groups of the “Nosology and Classification of Gen-
etic Skeletal Disorders (2010 version)” was reported in
the literature. The number of published cases is listed in
Table 1. The 10 most frequently reported GSDs were
Marfan syndrome, osteogenesis imperfecta, fibrous dys-
plasia, mucopolysaccharidosis, multiple cartilaginous
exostoses, neurofibromatosis type 1 (NF1), osteopetrosis,
achondroplasia, enchondromatosis (Ollier), and osteopoi-
kilosis, accounting for 76.5% of cases (12,312 cases). Fivegroups (group 8 TRPV4 group, group 12 spondylometaphy-
seal dysplasias, group 14 severe spondylodysplastic dyspla-
sias, group 18 bent bones dysplasias, and group 21
chondrodysplasia punctata) described in the Nosology have
not been reported yet by Chinese biomedical literature.
The geographic distribution of cases is shown in Figure 1.
GSDs have been reported in all of China’s provinces and
province-level municipalities. However, the number of
cases varied geographically. More patients were reported
in the East and South of China, which have a higher
population density and better medical services than other
areas. Beijing, Guangdong, Shandong, Shanghai and
Jiangsu ranked among the top 5 provinces or province-
level municipalities where disorders were reported.
As shown in Figure 2, the number of patients with
GSDs reported each year in the CBM database increased
gradually since 1978 and rapidly increased starting in
1994. Most GSD cases were reported by pediatricians,
radiologists, and orthopedists. 49.0% of the cases were
diagnosed at a university hospital,10.8% were diagnosed
at a provincial hospital, 32.7% were diagnosed at a muni-
cipal hospital, and the remainder (7.5%) was diagnosed
at hospitals on country level or even from smaller com-
munities. (Figure 3).
Gene mutations were evaluated in 187 cases or fam-
ilies out of 16,099 total reported cases, accounting for
only a minor portion (1.16%). As shown in Table 2, a
total of 37 genes for 41 different GSDs were reported,
including 43 novel mutations that have not been
reported before. The EXT1 and EXT2 genes (30 cases)
for multiple cartilaginous exostoses, the FBN1 gene for
Marfan syndrome (24 cases), and the FGFR3 gene for
achondroplasia (22 cases) were most frequently reported
in Chinese biomedical literature from the CBM database.
Compared to the reported geographic distribution of
GSDs (Figure 2), genetic testing was only performed at
university hospitals in a few areas (Figure 4). Affiliated
hospitals of Shanghai Jiaotong University, Chinese Acad-
emy Of Medical Science & Peking Union Medical Col-
lege, Zhongshan University, Central South University,
and Peking University rank the top 5 University hospi-
tals which performed most gene testing of GSDs.
Discussion
As the world’s most densely populated nation, China has
the world’s largest number of rare disease groups [5]. In
1984, the concept of rare diseases was introduced in
China. Until recently, however, the problem presented
by rare diseases has received little attention [6]. Cur-
rently, there is no case registration system for most rare
diseases, so there is very little documented information
on the epidemiology of those diseases in China [7].
China still lacks an official definition and spectrum of
rare diseases.
Table 1 Number of published cases of genetic skeletal diseases in Chinese and Europe biomedical literature listed in
alphabetical order of diseases*
Diseases or group of diseases Number of Cases reported in
Chinese biomedical literature
Number of published




Acrofacial dysostosis, Nager type 3 90
alpha-Mannosidosis 1 0.1
Apert syndrome 16 1.25
Asphyxiating thoracic dysplasia 45 150
Brachydactyly 88 80
Caffey disease 280 N.A.
Calcium pyrophosphate deposition disease (familial
chondrocalcinosis) type 2
1 N.A.




Chondrodysplasia punctata 7 0.5
Chondroectodermal dysplasia (Ellis–van Creveld) 11 150
Cleidocranial dysplasia 260 N.A
Congenital contractural arachnodactyly 7 N.A.
Craniofrontonasal syndrome 1 3
Craniometaphyseal dysplasia 4 70
Craniostenosis (Craniosynostosis) 302 72
Crouzon syndrome 161 2
Currarino triad 31 1
de Lange syndrome 7 1.9
Diaphyseal dysplasia Camurati-Engelmann 14 200
Dysplasia epiphysealis hemimelica (Trevor) 53 N.A.
Ectrodactyly-ectodermal dysplasia cleft-palate syndrome 5 N.A.
Ehlers–Danlos syndrome 57 0.2
Enchondromatosis (Ollier) 369 600
Enchondromatosis with hemangiomata (Maffucci) 80 250
Endosteal hyperostosis, van Buchem type 8 N.A.
Familial expansile osteolysis 1 N.A.
Familial hip dysplasia (Beukes) 45 N.A.
Familial osteochondritis dissecans 1 N.A.
Fanconi anemia 107 0.3
Fibrous dysplasia, polyostotic form 982 <50
Frontometaphyseal dysplasia 1 <30
Frontonasal dysplasia 4 N.A.
Fucosidosis 1 100
Fuhrmann syndrome 1 11
GM1 Gangliosidosis, several forms 7 N.A.
Grebe dysplasia 2 N.A.
Greig cephalopolysyndactyly syndrome 2 100
Hajdu–Cheney syndrome 7 N.A.
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Table 1 Number of published cases of genetic skeletal diseases in Chinese and Europe biomedical literature listed in
alphabetical order of diseases* (Continued)
Hallermann–Streiff syndrome 32 <100
Hanhart syndrome(hypoglossia-hypodactylia) 1 <50
Holt-Oram syndrome 218 1
Hypertrophic osteoarthropathy 36 N.A.
Hypochondroplasia 3 3.3
Hypophosphatasia, perinatal lethal and infantile forms 19 N.A.
Hypophosphatemic rickets 43 <100
Idiopathic juvenile osteoporosis 1 5
Immuno-osseous dysplasia (Schimke) 3 50
Infantile systemic hyalinosis/Juvenile hyaline fibromatosis
(ISH/JHF)
3 N.A.
Klippel-Feil anomaly with laryngeal malformation 318 2
Kniest dysplasia 1 2
Langer type (Homozygous dyschondrosteosis) 2 N.A.
Larsen syndrome 9 100
Lipomembraneous osteodystrophy with






Marfan syndrome 5064 20
Marshall syndrome 2 63
Meckel syndrome 35 2.5
Melorheostosis 153 300
Melorheostosis with osteopoikilosis 6 N.A.
Mesomelic dysplasia 4 2
Metaphyseal dysplasia, Jansen type 3 16
Metaphyseal dysplasia, Schmid type (MCS) 53 N.A.
Mucolipidosis II (I-cell disease),alpha/beta type 2 0.15
Mucopolysaccharidosis 958 3.56
Multicentric carpal-tarsal osteolysis with and without
nephropathy
2 <10
Multiple cartilaginous exostoses 911 2
Multiple epiphyseal dysplasia 122 5
Multiple sulfatase deficiency 1 50
Multiple synostoses syndrome 1 20
Nail-patella syndrome 61 2
Neonatal hyperparathyroidism, severe form 4 N.A.
Neurofibromatosis type 1 (NF1) 881 25
Oculodentoosseous dysplasia 8 243
Omodysplasia 1 30
Oral-facial-digital syndrome 15 1.2
Osteoectasia with hyperphosphatasia (juvenile
Paget disease)
4 50
Osteogenesis imperfecta 1314 6.5
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Pallister-Hall syndrome 1 100
Parietal foramina 11 5
Pfeiffer syndrome 4 1
Poland anomaly 27 3
Preaxial polydactyly 16 25
Progeria, Hutchinson–Gilford type 20 0.005
Progressive osseous heteroplasia 20 N.A.
Progressive pseudorheumatoid dysplasia (PPRD; SED with
progressive arthropathy)
6 N.A.
Proteus syndrome 22 200
Proximal symphalangism 15 N.A.
Pseudoachondroplasia (PSACH) 51 1.6
Pyknodysostosis 14 0.13
Pyle disease 2 <30
Radio-ulnar synostosis 55 <20
Saethre–Chotzen syndrome 1 3
Schwartz–Jampel syndrome (myotonic chondrodystrophy) 4 100
SED tarda, X-linked (SED-XL) 156 0.55
SED, Wolcott–Rallison type 1 <60
Short rib-polydactyly syndrome 57 N.A.
Shprintzen-Goldberg syndrome 1 <50
Sotos syndrome 38 7
Split hand-foot malformation 25 1.1
Spondylocostal dysostosis 1 4
Spondyloepiphyseal dysplasia congenita (SEDC) 50 0.34
Spondylometaphyseal dysplasia 6 1
Spondylometaphyseal dysplasia, Kozlowski type 2 0.1
Sterile multifocal osteomyelitis,periostitis, and pustulosis
(CINCA/NOMID-like)
1 N.A.
Stickler syndrome 7 13.5
Syndactyly type 5 (HOXD13) 7 N.A.
Thanatophoric dysplasia 28 3.5
Thrombocytopenia-absent radius 1 N.A.
Tibial hemimelia 2 0.1
Trichorhinophalangeal dysplasia 15 >100
*: Different types belong to one diseases have been combined as one item when the typing information was not provided in literature.
Cui et al. Orphanet Journal of Rare Diseases 2012, 7:55 Page 5 of 13
http://www.ojrd.com/content/7/1/55A bibliographic study will help to estimate the preva-
lence of rare diseases [8]. Most rare diseases have been
reported in Chinese biomedical publications. Presently,
only 86 Chinese biomedical journals have abstracts in
English included in Pubmed [9]. Therefore, most reports
on rare diseases in China are unavailable to internationalreaders. To our knowledge, the current study is the first
systematic review of the Chinese biomedical literature
on rare disease groups.
GSDs are representative for many other groups of rare
diseases. The current systematic review found that the
number and type of GSDs reported in Chinese biomedical
Figure 1 Geographic distribution of reported cases of genetic skeletal disorders (GSDs) in Chinese biomedical literature. The number of
cases reported varied geographically, and focused in the East and South of China. Beijing, Guangdong, Shandong, Shanghai and Jiangsu ranked
among the top 5 provinces or province-level municipalities where GSDs were reported.
Cui et al. Orphanet Journal of Rare Diseases 2012, 7:55 Page 6 of 13
http://www.ojrd.com/content/7/1/55literature increased gradually over the past 30 years. In
the last 5 years in particular, there were 1,057 cases
reported annually, which is due to the rapid improvement
of general healthcare and increasing attention to the med-
ical problems caused by rare diseases in China. Although
most genetic skeletal disease groups have been reported
in Chinese biomedical literature, but only a small portion
of patients were exactly molecularly characterized. For ex-
ample, 1,314 cases of osteogenesis imperfecta were
reported in the CBM database but in only 5% the exacttype has been determined. This situation might be mainly
due to the fact that most of these patients were diagnosed
based on clinical and radiographic criteria and because
gene mutation testing has been unavailable at most hospi-
tals until now. In only 1% of all cases with GSDs a causa-
tive gene mutation was identified. Among these reported
mutations, there is a relatively high frequency of novel
mutations. These novel variations may also lead to a bet-
ter understanding of the mutation spectrum and impact
of genes associated with GSDs. For example, 5 cases of
Figure 2 Case number of genetic skeletal disorders reported in Chinese biomedical literatures from 1978 to 2011. The number of GSDs
reported each year in the CBM database increased gradually since 1978 and rapidly increased starting in 1994. 1,057 cases were reported annually
in recent 5 years.
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ese biomedical literature. Among them, 4 cases belong to
glycine single base substitution mutations in the triple-
helical region (p.G632x, p.G1157D) and splicing sites
(IVS27+ 1 G>A, IVS8-2A>G), which are the most and
second common mutation types in COL1A1 gene. Muta-
tions in the C-propeptide coding region have been identi-
fied less frequent than other forms of mutation. D1441 is
one of a few residues absolutely conserved in this region,Figure 3 Hospital distribution of reported cases of genetic
skeletal disorders in Chinese biomedical literatures. Most of the
GSDs were diagnosed in hospitals in cities including university
hospitals (49.0%), provincial hospitals (10.8%), and municipal hospital
(32.7%). Only 7.5% of GSD cases were reported by hospitals on
country level and below, which account for about 70% of the
medical resources in China.a previous study reported a defect in this site (D1441Y)
resulting in a lethal variant of osteogenesis imperfecta
with features of dense bone diseases [10], however, a
novel mutation in this site described in a Chinese family
(D1441H) led to only mild osteogenesis imperfecta (type
1), which suggesting mutations in this region show great
heterogeneity in clinical outcome.
This systematic review of genetic skeletal diseases also
revealed that reporting of rare diseases varies signifi-
cantly in different regions and medical resources avail-
able in China. Cases of rare diseases were more
frequently reported in large municipalities such as Bei-
jing and Shanghai instead of areas with a larger popula-
tion but a relatively lower level of development such as
Sichuan and Henan Provinces. Country level hospitals
and below are mainly responsible for treating rural resi-
dents and represent more than 70% of the medical
resources in China [11]. In this review, we found that
only 7.5% of the cases of rare diseases were diagnosed by
these hospitals, which is significantly lower than that
diagnosed by urban hospitals. In actuality, there are also
significant disparities in health care between university
hospitals and provincial and municipal hospitals. Cur-
rently, gene mutation testing for genetic rare diseases in
China is done only by university hospitals in several key
municipalities.
We further compared the number of GSD cases
reported in Chinese biomedical literature with those of
published cases or estimated prevalence of these diseases
in Europe from bibliographic data issued by Orphanet
Table 2 Gene mutation of genetic skeletal disorders published in Chinese biomedical literature from 1978 to 2012*
Gene Name of disorder MIM No. No. of
case
reported*




135100 2 c.617 G>A (p.R206H) exon 4 missense
1 c.1067 G>A (p.G356D) exon 7 missense
ALPL Hypophosphatasia,
infantile forms
241500 1 c.18delA and c.G407C
(p.V7Yfs18X and p.R136P)





146300 1 c.1366 G>A (p.G456R) exon 12 missense
1 c.1581C>G (p.P446G) exon 12 missense yes
1 c.583 G>A (p.R136H) exon 5 missense
CLCN5 Dent’s disease 300554 1 p.L594fsX595 exon 10 nonsense yes
1 p.R637X exon 10 nonsense
1 p.R467X exon 9 nonsense
1 p.IVS4-2A>G exon 4 splicing yes
1 c.1022C> T (p.S244L) exon 7 missense
1 c.1805 T >G (p.V505G) exon 9 missense yes
CLCN7 Osteopetrosis,
late-onset form type 2
(OPTA2)
166600 1 c.C856T (p.R286W) exon 10 missense
COL1A2 Osteogenesis
imperfecta
1 c.A3350G (p.Y1117C) exon 49 missense
1 c.G3305C (p.G1102A) exon 49 missense
COL1A1 Osteogenesis
imperfecta
166220 1 c.1678 G>A (p.G560S) exon 25 missense
166200 1 p.Gly632x exon 28 nonsense yes
166200 1 p.D1441H exon 52 missense yes
166200 1 c.1875 + 1 G>A (IVS 27 + 1 G>A) intron 27 splicing yes
166200 1 IVS8-2A>G intron 8 splicing yes
1 c.2461 G>A (p.G821S) exon 36 missense




183900 1 c.1510 G>A (p.G504S) missense
1 c.2401 G>A (p.G801S) missense
EFNB1 Craniofrontonasal
Syndrome
304110 1 c.161C>G (p.P54R) exon 2 missense yes
COMP Pseudoachondroplasia 177170 1 c.815 T > C (p.L272P) exon 8 missense
EIF2AK3 SED, Wolcott–Rallison
type
226980 1 c.1408-1409insT and c.1596 T >A
(p.S470FfsX7 and p.C532X)
exon 8 and 9 nonsense
EXT1 Multiple cartilaginous
exostoses 1
133700 1 c.1564-7delC exon 7 frameshift yes
1 I8 + 2 T >G intron 8 splicing yes
1 c.651_664delinsTTT (p.K218fsX220) exon 1 nonsense
1 c.680delG (p.R227fs) exon 1 frameshift
1 c.1182delG (p.Arg394SerfsX9) exon 4 nonsense yes
1 c.1108 G> T (p.E370X) exon 3 nonsense yes
1 c.335delA (p.Asn112ThrfsX24) exon 1 nonsense yes
1 c.361C> T (p.Q121X) exon 1 nonsense yes
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(Continued)
1 c.1879_1881delCAC (p.His627del) exon 9 In frame deletion yes
1 c.651_664delinsTTT (p.K218fsX220) exon 1 frameshift
1 1633-26(C>A) intron 7 splicing
1 c.2120delT exon 6 frameshift
1 c.811 T > C (p.Y271H) exon 1 missense yes
EXT2 Multiple cartilaginous
exostoses 2
133701 1 c.668 G>C (p.Arg223Pro) exon 2 missense
1 c.950delT (p.Phe317SerfsX15) exon 6 nonsense yes
3 c.1016 G>A (p.Cys339Tyr) exon 6 missense
1 c.398 T >G (p.L133R) exon 2 missense
1 c.751C> T (p.Q251X) exon 5 missense
1 c.544C> T (p.R182X) exon 3 missense
1 c.536 G>A (p.Arg179Lys) exon 2 missense
1 c.1006C> T (p.G1n336X) exon 6 nonsense yes
1 IVS2 + 1 G>A intron 2 splicing
1 IVS7 + 1 G> T intron 7 splicing
1 c.789-796delTGTT exon 5 frameshift yes
1 c.637 G>A exon 4 nonsense
1 c.313A> T (p.Lys105X) exon 2 nonsense
1 319insGT exon 2 frameshift
1 536+ 1 G>A (IVS2 + 1 G>A) intron 2 splicing
FBN1 Marfan syndrome 154700 1 c.3463 G>A (p.Asp1155Asn) exon 27 missense yes
1 c.5015 G>C (p.C1672S) exon 40 missense
3 c.5309 G>A (p.C1770Y) exon 43 missense
2 c.7241 G>A (p.R2414Q) exon 58 missense
2 c.7769 G>A (p.C2590Y) exon 62 missense
2 c.2261A>G (p.Y754C) exon 18 missense
1 c.[6862_6871delGGCTGTGTAG;
6871 + 1_6871+ 11delGTAAGAGGATC]
(p.Gly2288MetfsX109)
exon 55 nonsense yes
1 c.2462 G>A (p.Cys821Tyr) exon 20 missense yes
1 c.5015 G>C (p.C1672S) exon 40 missense
1 c.3295 G> T (p.E1099X) exon 26 nonsense
2 c.4307insTCGT (p.G1441X) exon 34 nonsense yes
1 c.4621C> T (p.R1541X) exon 37 nonsense
1 c.8080C> T (p.A2694X) exon 64 nonsense
2 IVS29+ 4A> T intron 29 splicing
1 IVS50+ 1 G>A intron 50 splicing
1 c.3069 G> T (p.Lys1023Asn) exon 24 missense yes
1 c.3243-3256delGCCTCTGCACCCA exon 25 frameshift
FGFR1 Pfeiffer syndrome 101600 1 c.755C>G (p.Pro252Arg) exon 5 missense
FGFR2 Pfeiffer syndrome 101600 1 IVS8 A >G exon 8 splicing
1 p.Asp321Ala exon 9 missense
Apert syndrome 101200 1 c.934C>G (p.S252W) exon 7 missense
Crouzon syndrome 123500 1 c.833 G> T (p.C278F) exon 8 missense
1 p.Tyr340His exon 9 missense
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Table 2 Gene mutation of genetic skeletal disorders published in Chinese biomedical literature from 1978 to 2012*
(Continued)
1 p.Cys342Trp exon 9 missense yes
1 p.Cys342Tyr exon 9 missense
1 p.Ala344Ala exon 9 missense
1 p.Gly338Arg exon 9 missense
1 p.Ala344Gly exon 9 missense
1 p.Gln289Pro exon 7 missense
FGFR3 Achondroplasia 100800 21 c.1138 G>A (p.G380R) exon 10 missense
1 p.Ser217Cys exon 5 missense
FGFR3 Thanatophoric
dysplasia
187600 1 c.742C> T (p.R248C) exon 7 missense
GALNS Mucopolysaccharidosis
type 4A





186500 2 c.1471 G>A (p.E491K) exon 2 missense
GNAS1 Albright hereditary
osteodystrophy
103580 1 1-bp (C) deletion at codon 291 exon 11 frameshift
HLXB9 Currarino triad 176450 2 c.552C>G (p.Tyr184X) nonsense
TP63 Split hand-foot
malformation, isolated
form, type 4 (SHFM4)
605289 1 c.956 G>A (p.R280H) exon 7 missense
HOXD13 Synpolydactyly 186000 1 c.32 G>C (p.G11A) exon 1 missense
1 c.64 G> T (p.A22S) exon 1 missense yes
3 9-residue polyalanine expansion exon 1
yes
1 8-residue polyalanine expansion exon 1
1 7-residue polyalanine expansion exon 1
IDS Mucopolysaccharidosis
type 2
309900 1 c.892C> T (p.Q298X) exon 7 nonsense
1 c.1468delA exon 9 frameshift
1 c.263 G>A (p.Arg88His) exon 3 missense
1 1103_1123del19 exon 8 frameshift
IHH Brachydactyly type A1 112500 1 c.G298A (p.D100N) exon 1 missense
NF1 Neurofibromatosis type 1 162200 1 c.1009 G> T exon 7 nonsense yes
1 c.3443-3444delCA exon 20 frameshift yes
1 c.4339C> T (p.G1336X) nonsense
1 c.5839C> T (p.R1947X) exon 31 nonsense












307800 1 IVS20-1 G> T intron 20 splicing
1 c.1861C> T (p.GIn621X) exon 18 missense yes
PTPN11 Baller–Gerold
syndrome
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Table 2 Gene mutation of genetic skeletal disorders published in Chinese biomedical literature from 1978 to 2012*
(Continued)
ROR2 Brachydactyly type B 113000 1 c.2265C>A (p.Y755X) exon 9 nonsense
1 c.1398-1399insA exon 9 nonsense
RUNX2 Cleidocranial dysplasia 119600 1 c.346 T >A (p.W116R) exon 1 missense
1 c.610A> T (p.K204X) exon 3 nonsense
1 c.346 T >A (p.W116R) exon 1 missense
1 c.475 G>C (p.G159R) exon 2 missense yes
1 c.673C> T (p.R225W) exon 3 missense
1 c.1171C>G (p.R391X) exon 7 nonsense




107480 4 c.1792 G>C exon 2 missense
SEDL SED tarda, X-linked
(SED-XL)
313400 1 c.218C> T (p.S73L) exon 4 missense
1 c.370-371insA (p.S124fsX127) exon 6 nonsense yes
1 c.218C> T (p.S73L) exon 4 missense
1 c.239A>G (p.H80R) exon 4 missense
1 c.G209A exon 4 nonsense
1 c.262-266delGACAT exon 5 frameshift
1 D109-S123del (p.S124fsX126) intron 5-exon 6 nonsense
1 IVS5-2-1delAG322-332delTTTTCAATGAA intron 5-exon 6 splicing yes
1 IVS2-2A>C intron 2
SH3BP2 Cherubism 118400 5 c.1505 G>C (p.Arg415Pro) exon 9 missense
2 c.G1520A (p.Gly420Glu) exon 9 missense
SHOX Dyschondrosteosis 127300 1 c.115 T >G exon 2
1 c.1171-1172insA exon 3 frameshift
1 c.996A> T (p.E102V) exon 3 missense
SOX9 Campomelic dysplasia
(CD)
114290 1 p.R178L exon 2 missense yes
TBX5 Holt-Oram syndrome 142900 1 c.416delC exon 4 frameshift
1 c.145C>A exon 2 missense
1 c.161 T > C exon 2 missense
TGFbeta1 Diaphyseal dysplasia
Camurati-Engelmann


























*: “Pedigree mutation”, that is an identical mutation has been reported in more than one affected siblings in a family, was counted as one case. Mutation
information was extracted from the full text, as its original description, all the novel mutations were claimed in the papers by the authors, and then were
confirmed by searching the previous literature and the Human Gene Mutation Database.
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http://www.ojrd.com/content/7/1/55[8] (Table 1). Generally, the number of GSDs reported in
Chinese biomedical literatures is lower than in Europe,
but, with some exceptions, the proportions between thedifferent entities are similar. One of these exceptions are
the multiple epiphyseal dysplasias, whose frequency in
Europe is 5/100,000, while only a total of 122 cases were
Figure 4 Geographic distribution of reported genetic skeletal disorders with gene mutation testing in Chinese biomedical literature.
Genetic testing for GSDs was only performed at university hospitals in a few areas, far less than the regions where GSDs were reported.
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http://www.ojrd.com/content/7/1/55reported in Chinese biomedical literature in the past
34 years. Although publication bias and genetic differ-
ences between Caucasian and Asian people may exist,
we think this discrepancy is mainly due to the fact that
China is still lagging behind Europe in terms of themedical resources for these rare diseases, especially in
the widespread underdeveloped regions and hospitals on
basic levels, therefore, many patients with genetic skel-
etal disorders could not acquire proper and timely diag-
nosis in China.
Cui et al. Orphanet Journal of Rare Diseases 2012, 7:55 Page 13 of 13
http://www.ojrd.com/content/7/1/55Creating a network for rare diseases is an important med-
ical policy that should significantly reduce misdiagnosis and
improve the level of treatment. A network for collabor-
ation with national medical resources has been set up in
countries and regions such as Europe, North America,
and Japan [12,13]. A number of centers offering counsel-
ing on rare diseases have been established in major Chin-
ese cities and several provinces, but a national network
has yet to be created. Given the fact that there is a huge
gap in terms of medical services in different areas and
hospital levels of China, a stronger network of diagnosis
and treatment including all levels of hospitals across the
country should be created to improve healthcare for rare
diseases in the future.
Conclusion
In conclusion, this systematic review summarized the
number, geographic and genetic characteristics of GSDs
in Chinese biomedical publications. Analyzing number
of the diseases revealed an imbalance in the distribution
of areas and hospitals diagnosing rare diseases, which
suggests that a multi-level network should be created to
meet the specific challenge of healthcare for rare dis-
eases in China.
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